Gilead Sciences (GILD) Non-Current Debt (2010 - 2026)

Gilead Sciences (GILD) has reported Non-Current Debt for 17 consecutive years, with $20.9 billion the latest figure, recorded in Q1 2026.

• Non-Current Debt for Q1 2026 came in at $20.9 billion, down 5.8% year-over-year; the trailing twelve-month figure through Mar 2026 was $20.9 billion (down 5.8% YoY), and the FY2025 annual result was $22.1 billion, down 11.11% from the prior year.
• Non-Current Debt was $20.9 billion for Q1 2026 at Gilead Sciences, down from $22.1 billion in the prior quarter.
• Over five years, Non-Current Debt peaked at $25.2 billion in Q2 2022 and troughed at $20.9 billion in Q1 2026.
• Average Non-Current Debt over 5 years is $22.7 billion, with a median of $22.1 billion recorded in 2025.
• Year-over-year, Non-Current Debt slipped 15.82% in 2023 and grew 7.36% in 2024.
• Over 5 years, Non-Current Debt stood at $23.0 billion in 2022, then rose by 1.01% to $23.2 billion in 2023, then grew by 7.36% to $24.9 billion in 2024, then declined by 11.11% to $22.1 billion in 2025, then dropped by 5.73% to $20.9 billion in 2026.
• Per Business Quant data, the three most recent Non-Current Debt figures were $20.9 billion in Q1 2026, $22.1 billion in Q4 2025, and $22.1 billion in Q3 2025.